feed,title,long_url,short_url
BioRxiv,Nucleocapsid 203 mutations enhance SARS-CoV-2 immune evasion,https://biorxiv.org/cgi/content/short/2021.12.20.473471v1?rss=1,https://j.mp/3eiO34X
BioRxiv,Construction of a potent pan-vaccine based on the evolutionary tendency of SARS-CoV-2 spike protein,https://biorxiv.org/cgi/content/short/2021.12.21.473594v1?rss=1,https://j.mp/3srJYUB
BioRxiv,Anti-SARS-CoV-2 human antibodies retaining neutralizing activity against SARS-CoV-2 B.1.1.529 (omicron),https://biorxiv.org/cgi/content/short/2021.12.21.473706v1?rss=1,https://j.mp/3pnBY4X
BioRxiv,Structural basis for antibody resistance to SARS-CoV-2 omicron variant,https://biorxiv.org/cgi/content/short/2021.12.21.473620v1?rss=1,https://j.mp/3EoxQpF
